[go: up one dir, main page]

NO20082727L - Salter av 9-oksoakridin-10-eddiksyre med 1-alkylamino-1-deoksypolyoler - Google Patents

Salter av 9-oksoakridin-10-eddiksyre med 1-alkylamino-1-deoksypolyoler

Info

Publication number
NO20082727L
NO20082727L NO20082727A NO20082727A NO20082727L NO 20082727 L NO20082727 L NO 20082727L NO 20082727 A NO20082727 A NO 20082727A NO 20082727 A NO20082727 A NO 20082727A NO 20082727 L NO20082727 L NO 20082727L
Authority
NO
Norway
Prior art keywords
oxoacridine
alkylamino
acetic acid
salts
formula
Prior art date
Application number
NO20082727A
Other languages
English (en)
Inventor
Kirill Gennadievich Surkov
Original Assignee
Ephag As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ephag As filed Critical Ephag As
Publication of NO20082727L publication Critical patent/NO20082727L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D219/00Heterocyclic compounds containing acridine or hydrogenated acridine ring systems
    • C07D219/04Heterocyclic compounds containing acridine or hydrogenated acridine ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C07D219/06Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/08Solutions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)

Abstract

Oppfinnelsen angår salter av 1-alkylamino-1-deoksypolyoler og 9-oksoakridin-10-eddiksyre med den generelle formelen (I): (I) hvori A+ er (II) (II) hvori R er valgt fra gruppen bestående av etyl, propyl, butyl, medisinske preparater som innebefatter som en aktiv ingrediens salter med formel (I) og/eller en blanding av nevnte salt med formel (I) eller 9-oksoakridin-10-eddiksyre med formelen: (III) og en eller flere1-alkylamino-1-deoksypolyoler med den generelle formelen (II): hvori: (II) R er valgt fra gruppen bestående av etyl, propyl, butyl.
NO20082727A 2005-11-21 2008-06-19 Salter av 9-oksoakridin-10-eddiksyre med 1-alkylamino-1-deoksypolyoler NO20082727L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU2005136819/04A RU2326115C2 (ru) 2005-11-21 2005-11-21 Соли 1-алкиламино-1-дезоксиполиолов с 9-оксоакридин-10-уксусной кислотой, лекарственные препараты на их основе, применение, способы профилактики и лечения
PCT/RU2006/000614 WO2007058568A2 (fr) 2005-11-21 2006-11-17 Sels et melanges d'acide 9-oxoacridine-10-acetique et de 1-alkylamino-1-desoxypolyols, compositions pharmaceutiques les contenant, et methodes de traitement associees

Publications (1)

Publication Number Publication Date
NO20082727L true NO20082727L (no) 2008-08-20

Family

ID=38049089

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20082727A NO20082727L (no) 2005-11-21 2008-06-19 Salter av 9-oksoakridin-10-eddiksyre med 1-alkylamino-1-deoksypolyoler

Country Status (17)

Country Link
US (1) US7846939B2 (no)
EP (1) EP1970372B1 (no)
KR (1) KR20080071182A (no)
CN (1) CN101370783B (no)
AT (1) ATE486852T1 (no)
BR (1) BRPI0620530A2 (no)
CA (1) CA2631166A1 (no)
DE (1) DE602006018065D1 (no)
DK (1) DK1970372T3 (no)
ES (1) ES2355435T3 (no)
MX (1) MX2008006545A (no)
NO (1) NO20082727L (no)
PL (1) PL1970372T3 (no)
RU (1) RU2326115C2 (no)
SI (1) SI1970372T1 (no)
UA (1) UA93529C2 (no)
WO (1) WO2007058568A2 (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA110918C2 (uk) * 2008-04-16 2016-03-10 Ховард Юніверсіті Інгібітори протеїнфосфатази-1 та їх застосування
PT107894A (pt) 2011-10-21 2014-10-31 Abbvie Inc Métodos para o tratamento de hcv compreendendo pelo menos dois agentes antivirais de actuação directa, ribavirina, mas não interferão.
US8492386B2 (en) 2011-10-21 2013-07-23 Abbvie Inc. Methods for treating HCV
GB2515942A (en) 2011-10-21 2015-01-07 Abbvie Inc Combination treatment (e.g. with ABT-072 or ABT-333) of DAAs for use in treating HCV
US8466159B2 (en) 2011-10-21 2013-06-18 Abbvie Inc. Methods for treating HCV
US11192914B2 (en) 2016-04-28 2021-12-07 Emory University Alkyne containing nucleotide and nucleoside therapeutic compositions and uses related thereto
RU2730530C1 (ru) * 2019-10-29 2020-08-24 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Новое химическое соединение L-лизина 9-оксоакридинил-10-ацетат, стимулирующее продукцию интерлейкина-24 и фактора некроза опухолей - бета
RU2753136C1 (ru) * 2020-10-15 2021-08-11 Оксана Владимировна Владимирова Способ аутодермопластики расщепленным кожным лоскутом для восстановления кожного покрова при ожогах
WO2025110809A1 (ko) * 2023-11-23 2025-05-30 주식회사 미토이뮨테라퓨틱스 신규한 디하이드로아크리딘 유도체, 및 이를 포함하는 약학적 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532081A1 (de) * 1985-09-09 1987-03-12 Orion Yhtymae Oy Mischsalze von glucosaminsulfat und verfahren zu ihrer herstellung
CZ283038B6 (cs) * 1991-01-11 1997-12-17 Laboratoires Glaxo Sa Akridinové deriváty, způsob výroby a farmaceutické prostředky s jejich obsahem
RU2031650C1 (ru) 1992-03-17 1995-03-27 Гринберг Григорий Ефимович Противовирусное лекарственное средство и способ его получения
RU2020941C1 (ru) 1992-07-06 1994-10-15 Олег Викторович Травкин Способ получения противовирусного средства
RU2036198C1 (ru) 1993-04-01 1995-05-27 Товарищество с ограниченной ответственностью "Полисан" N-МЕТИЛ-N-( α,D -ГЛЮКОПИРАНОЗИЛ) АММОНИЯ-2-(АКРИДОН-9-ОН-10-ИЛ)АЦЕТАТ(ЦИКЛОФЕРОН), ОБЛАДАЮЩИЙ ИНТЕРФЕРОНОГЕННОЙ, ПРОТИВОВИРУСНОЙ, В ТОМ ЧИСЛЕ АНТИВИЧ, АНТИПАРАЗИТАРНОЙ, АНТИПРОМОТОРНОЙ И РАДИОПРОТЕКТИВНОЙ АКТИВНОСТЬЮ
RU2135474C1 (ru) * 1998-08-19 1999-08-27 Травкин Олег Викторович Соли 1-дезокси-1-n-метиламиногексаспиртов с n-акридонуксусной кислотой, обладающие иммуномодулирующей активностью, и лекарственное средство на их основе
RU2182004C1 (ru) 2001-02-22 2002-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Лекарственный препарат для парентерального применения
RU2197248C2 (ru) * 2001-03-20 2003-01-27 Травкин Олег Викторович Лекарственный препарат, обладающий иммуномоделирующим, иммунокоррегирующим, противопаразитарным, противосклеротическим, противовирусным, противобактериальным, противогрибковым, противовоспалительным и противоопухолевым действием, и способ его приготовления

Also Published As

Publication number Publication date
UA93529C2 (ru) 2011-02-25
US20100144780A1 (en) 2010-06-10
SI1970372T1 (sl) 2011-04-29
BRPI0620530A2 (pt) 2011-11-16
DK1970372T3 (da) 2011-02-07
ES2355435T3 (es) 2011-03-25
CA2631166A1 (en) 2007-05-24
WO2007058568A3 (en) 2007-10-04
RU2005136819A (ru) 2007-05-27
CN101370783B (zh) 2013-03-27
CN101370783A (zh) 2009-02-18
KR20080071182A (ko) 2008-08-01
PL1970372T3 (pl) 2011-04-29
WO2007058568A2 (fr) 2007-05-24
US7846939B2 (en) 2010-12-07
EP1970372B1 (en) 2010-11-03
MX2008006545A (es) 2009-01-16
RU2326115C2 (ru) 2008-06-10
ATE486852T1 (de) 2010-11-15
DE602006018065D1 (de) 2010-12-16
EP1970372A2 (en) 2008-09-17

Similar Documents

Publication Publication Date Title
NO20082727L (no) Salter av 9-oksoakridin-10-eddiksyre med 1-alkylamino-1-deoksypolyoler
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20091560L (no) Biaryleterureaforbindelser
NO20091858L (no) Hydrobenzamid derivater som inhibitorer av HSP90
NO20085066L (no) 4,5-difenyl-pyrimidinyl-aminosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20085067L (no) 4,5-difenyl-pyrimidinyl substituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20055568L (no) Substituerte 1,4-diazepiner og anvendelser derav
UA83057C2 (ru) Замещенные производные диоксида тиазолбензоизотиазола и их применение
NO20092286L (no) Nitrogenhaldige heterosykliske forbindelser og anvendelse derav
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
EA200801608A1 (ru) Производные бензимидазолонкарбоновой кислоты
NZ591814A (en) Pesticidal composition comprising an alpha-alkoxyphenyl acetic acid derivative and a neonicotinoid compound
NO20080110L (no) Benzimidazolderivativer som 5-HT6,5-HT24
WO2007017728A3 (en) Novel heterocyclic compounds
NO20063865L (no) Heterocyklisk substituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
NO20073702L (no) Ikke-steroid glukocorticoid reseptor modulatorer
NO20044881L (no) Acyl-3-karboksyfenylureaderivater, fremstillingsfremgangsmate og anvendelse derav
NO20060718L (no) Substituerte tiofoner og deres anvendelse
NO20063859L (no) Cykloalkylsubstituerte 7-amino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav og anvendelse derav som medikamenter
MY153733A (en) Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
NO20092413L (no) Pyrazolanaloger
NO20063860L (no) 7-fenylamino-4-kinolon-3-karboksylsyrederivater, fremgangsmate for fremstilling derav samt deres anvendelse som legemidler
NO20054418L (no) Substituert benzoylureidopyridylpiperidin- og -pyrrolidinkarboksylsyrederivater, deres fremstilling og anvendelse
WO2009017383A3 (en) Sustained-release formulation comprising metformin acid salt

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application